Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (801-810 of 955) with videos related to

Pageof 96
Sort By:
Pediatric Pulmonology|September 13, 2023
Codesign of remote data collection for chronic management of pediatric home mechanical ventilationCarolyn C Foster, Aaron J Kaat, Avani V Shah, et al.
Journal of Cancer Metastasis and Treatment|November 18, 2021
Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulatorsKimberly A Webster, Mary L O'Connor, Aaron R Hansen, et al.
Psychology Science Quarterly|March 26, 2010
Analysis of differential item functioning in the depression item bank from the Patient Reported Outcome Measurement Information System (PROMIS): An item response theory approachJeanne A Teresi, Katja Ocepek-Welikson, Marjorie Kleinman, et al.
The Lancet. Oncology|September 15, 2018
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trialFred Saad, David Cella, Ethan Basch, et al.
Eclinicalmedicine|August 8, 2024
Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extensionAlexander Röth, Catherine M Broome, Wilma Barcellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES StudyBernard Escudier, Camillo Porta, Petri Bono, et al.
Gynecologic Oncology|September 22, 2021
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG studyLari Wenzel, Helen Q Huang, David Cella, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 22, 2011
Advancing PROMIS's methodology: results of the Third Patient-Reported Outcomes Measurement Information System (PROMIS(®)) Psychometric SummitAdam C Carle, David Cella, Li Cai, et al.
Nature Reviews. Urology|May 27, 2026
Symptoms and subtypes of patients with lower urinary tract dysfunction - insights from the Symptoms of Lower Urinary Tract Dysfunction Research NetworkClaire C Yang, Ziya Kirkali, Anne P Cameron, et al.
Cancer|August 30, 2012
Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task ForceCharles S Cleeland, Jeff A Sloan, David Cella, et al.
Pageof 96

Showing results (801-810 of 955) with videos related to

Sort By:
Pageof 96
Pediatric Pulmonology|September 13, 2023
Codesign of remote data collection for chronic management of pediatric home mechanical ventilationCarolyn C Foster, Aaron J Kaat, Avani V Shah, et al.
Journal of Cancer Metastasis and Treatment|November 18, 2021
Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulatorsKimberly A Webster, Mary L O'Connor, Aaron R Hansen, et al.
Psychology Science Quarterly|March 26, 2010
Analysis of differential item functioning in the depression item bank from the Patient Reported Outcome Measurement Information System (PROMIS): An item response theory approachJeanne A Teresi, Katja Ocepek-Welikson, Marjorie Kleinman, et al.
The Lancet. Oncology|September 15, 2018
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trialFred Saad, David Cella, Ethan Basch, et al.
Eclinicalmedicine|August 8, 2024
Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extensionAlexander Röth, Catherine M Broome, Wilma Barcellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES StudyBernard Escudier, Camillo Porta, Petri Bono, et al.
Gynecologic Oncology|September 22, 2021
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG studyLari Wenzel, Helen Q Huang, David Cella, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 22, 2011
Advancing PROMIS's methodology: results of the Third Patient-Reported Outcomes Measurement Information System (PROMIS(®)) Psychometric SummitAdam C Carle, David Cella, Li Cai, et al.
Nature Reviews. Urology|May 27, 2026
Symptoms and subtypes of patients with lower urinary tract dysfunction - insights from the Symptoms of Lower Urinary Tract Dysfunction Research NetworkClaire C Yang, Ziya Kirkali, Anne P Cameron, et al.
Cancer|August 30, 2012
Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task ForceCharles S Cleeland, Jeff A Sloan, David Cella, et al.
Pageof 96